Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden · Delayed Price · Currency is SEK 6.26
-0.32 (-4.86%)
Nov 3, 2026, 5:29 PM CET
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 54.58 million as of November 3, 2026. It is the 44,336th most valuable company in the world and the 671st biggest in Sweden. Its market cap has decreased by 70.71% in one year.
Market Cap
54.58M
Enterprise Value
40.14M
Revenue
n/a
Global Rank
Country Rank
#671 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 54.58M, an increase of 8.69%. That is a compound annual growth rate of 0.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 54.58M | -60.95% |
| Dec 30, 2025 | 139.77M | -39.44% |
| Dec 30, 2024 | 230.78M | 161.10% |
| Dec 29, 2023 | 88.39M | -42.68% |
| Dec 30, 2022 | 154.19M | 12.35% |
| Dec 30, 2021 | 137.24M | 9.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 107.42M |
| Alzinova AB | 107.30M |
| Biovica International AB | 101.59M |
| OncoZenge AB | 82.53M |
| Ascelia Pharma AB | 74.11M |
| AcouSort AB | 67.30M |
| Pila Pharma AB | 66.01M |
| Nanologica AB | 54.25M |